Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infection
出版年份 2017 全文链接
标题
Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infection
作者
关键词
-
出版物
RHEUMATOLOGY
Volume 57, Issue 3, Pages 538-547
出版商
Oxford University Press (OUP)
发表日期
2017-11-24
DOI
10.1093/rheumatology/kex446
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cost-effectiveness of rituximab strategies in rheumatoid arthritis
- (2017) Raphaèle Seror et al. LANCET
- Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial
- (2016) Duncan Porter et al. LANCET
- Updated systematic review and meta-analysis of randomized controlled trials comparing low- versus high-dose rituximab for rheumatoid arthritis
- (2015) Markus Bredemeier et al. CLINICAL RHEUMATOLOGY
- Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial
- (2013) Xavier Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Low- Versus High-Dose Rituximab for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Markus Bredemeier et al. ARTHRITIS CARE & RESEARCH
- Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries
- (2011) K. Chatzidionysiou et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE
- (2011) Paul P Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
- (2010) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) D. Aletaha et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
- (2010) P. P. Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR)
- (2010) A. Rubbert-Roth et al. RHEUMATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started